The civic record
Read. Follow. Verify.North Carolina bans DEHP in IV bags by 2030 and IV tubing by 2035
Last action · April 28, 2025: Ref To Com On Rules and Operations of the Senate (Senate action)Sponsors: Tim Reeder and 11 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
North Carolina prohibits the manufacturing, selling, and distributing of intravenous solution containers containing starting January 1, 2030, and extends the prohibition to intravenous tubing starting January 1, 2035. The law also caps unintentionally added at 0.1 percent weight per weight and bars substitution with other s.
Manufacturers and distributors doing business in North Carolina must eliminate from certain medical devices or face administrative penalties of up to $5,000 per day per violation, altering supply chains for healthcare facilities across the state.
- DEHP is a widely used plasticizer in polyvinyl chloride (PVC) medical products that has been classified as a probable human carcinogen by the U.S. Environmental Protection Agency. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Manufacturers, sellers, and distributors of medical devices
Entities manufacturing or distributing intravenous solution containers and tubing must alter product composition to eliminate intentionally added DEHP and comply with unintentional concentration caps.
Hospitals and health care facilities
Facilities must source intravenous equipment that complies with the new DEHP prohibitions by the respective effective dates.
Key Facts
- Beginning January 1, 2030, manufacturing, selling, or distributing intravenous solution containers with intentionally added DEHP is prohibited in North Carolina.
- Beginning January 1, 2035, manufacturing, selling, or distributing intravenous tubing with intentionally added DEHP is prohibited in North Carolina.
- Replacing DEHP with another ortho-phthalate in a new or revised medical device is prohibited.
- Unintentionally added DEHP in intravenous solution containers or tubing is capped at a maximum quantity of 0.1 percent weight per weight (w/w).
Show all 7 facts
- Human blood collection and storage bags, as well as apheresis and cell therapy blood kits and bags including integral tubing, are exempt from the prohibitions.
- The Secretary may impose an administrative penalty of up to $5,000 for each day a violation of the new Article continues.
- DEHP is identified as an ortho-phthalate chemical used primarily to produce flexibility in plastics such as polyvinyl chloride.
Frequently Asked Questions
When do the bans on DEHP take effect?
Are all medical bags exempt from this legislation?
What is the penalty for violating the DEHP prohibitions?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently passed chamber. The next step in the legislative lifecycle is Law.
Procedural history
14 actions- Apr 28, 2025SenateRef To Com On Rules and Operations of the Senate
- Apr 28, 2025SenatePassed 1st Reading
- Apr 28, 2025SenateRegular Message Received From House
- Apr 17, 2025HouseRegular Message Sent To Senate
- Apr 16, 2025HousePassed 3rd Reading
- Apr 16, 2025HousePassed 2nd Reading
Show 8 earlier actions
- Apr 15, 2025HousePlaced On Cal For 04/16/2025
- Apr 15, 2025HouseCal Pursuant Rule 36(b)
- Apr 15, 2025HouseReptd Fav
- Apr 15, 2025HouseRe-ref Com On Rules, Calendar, and Operations of the House
- Apr 15, 2025HouseReptd Fav Com Substitute
- Apr 1, 2025HouseRef to the Com on Health, if favorable, Rules, Calendar, and Operations of the House
- Apr 1, 2025HousePassed 1st Reading
- Mar 31, 2025HouseIntroducedFiled
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 7 more sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Phased Phase-out of DEHP in Medical Devices
The legislation implements a staggered timeline, banning DEHP in intravenous solution containers in 2030 and extending the ban to intravenous tubing in 2035.
Connected Entities
Sources
www.ncleg.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy50Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools